These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17627753)

  • 1. Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'.
    Levine L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1081-2. PubMed ID: 17627753
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Topical Treatment for Acute Phase Peyronie's Disease Utilizing a New Gel, H-100: A Randomized, Prospective, Placebo-Controlled Pilot Study.
    Seftel AD
    J Urol; 2016 May; 195(5):1562-1564. PubMed ID: 27186765
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
    Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
    J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is intralesional verapamil effective therapy for Peyronie's disease?
    Levine LA; Costabile RA
    J Urol; 2012 Sep; 188(3):704-6. PubMed ID: 22818342
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
    Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
    J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
    Riedl CR; Sternig P; Gallé G; Langmann F; Vcelar B; Vorauer K; Wagner A; Katinger H; Pflüger H
    Eur Urol; 2005 Oct; 48(4):656-61. PubMed ID: 15982798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
    Cavallini G; Biagiotti G; Koverech A; Vitali G
    BJU Int; 2002 Jun; 89(9):895-900. PubMed ID: 12010235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effects of verapamil in the treatment of Peyronie's disease].
    Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
    Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
    Paulis G; D'Ascenzo R; Nupieri P; De Giorgio G; Orsolini G; Brancato T; Alvaro R
    Int J Androl; 2012 Aug; 35(4):521-7. PubMed ID: 21950543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical management of Peyronie's disease.
    Akin-Olugbade Y; Mulhall JP
    Nat Clin Pract Urol; 2007 Feb; 4(2):95-103. PubMed ID: 17287870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Review of Peyronie's disease].
    Stein A; Dekel Y
    Harefuah; 2012 Nov; 151(11):638-40, 653. PubMed ID: 23367736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
    Safarinejad MR
    Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
    Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
    J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of current nonsurgical management of Peyronie's disease.
    Levine LA
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S113-20. PubMed ID: 14551587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.
    Tuygun C; Ozok UH; Gucuk A; Bozkurt IH; Imamoglu MA
    Int Urol Nephrol; 2009; 41(1):113-8. PubMed ID: 18592390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.